OnKure Therapeutics, Inc. OKUR
2.90
(0.03)
(1.02%)
as of 25 Sep
- Market cap
- $118.7M
- P/E
- 0.0×
Follow OKUR
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
26.75 | 13.78 | 10.28 | 11.45 |
+8 more quarters Free account |
Net Debt/EBITDA |
10.56 | 12.46 | 4.24 | 4.60 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.67 | 0.85 | 0.85 | 0.89 | |
Capex/Depreciation |
(0.02) | (0.02) | (0.04) | (0.03) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.21) | (0.95) | (0.85) | (0.96) | |
Cash per Share |
3.54 | 14.05 | 4.37 | 5.20 | |
Shareholders Equity per Share |
3.45 | 13.48 | 4.16 | 4.91 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.45 | 13.48 | 4.16 | 4.91 | |
Free Cash Flow |
(10.36) | (12.94) | (11.52) | (13.04) | |
Working Capital |
171.03 | 183.15 | 54.92 | 65.28 | |
Capital Expenditures |
0.00 | 0.00 | (0.01) | (0.01) | |
Net Current Asset Value |
170.43 | 183.14 | 54.91 | 65.12 | |
| Other line items | |||||
Quick Ratio |
26.55 | 13.41 | 9.97 | 11.26 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.21) | (0.95) | (0.85) | (0.96) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
2.19 | 6.68 | 2.20 | 0.76 | |
Average Assets |
132.71 | 149.29 | 88.51 | 75.24 | |
Average Common Equity |
125.14 | 137.50 | 80.01 | 70.22 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates